Headlines

Pic: getty/daku

Synaffix and BigHat Biosciences collaborate to develop AI-designed ADC

BigHat will have access to the clinical-stage ADC platform technology designed by Lonza’s Synaffix.

Pic: getty/kobuslouw

EMA accepts Alvotech and Advanz Pharma’s Marketing Authorization Application for biosimilar of J&J’s Simponi

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

Pic: getty/andrewbrook

AbbVie acquires Aliada Therapeutics in $1.4 billion deal

The acquisition of Aliada Therapeutics will grant AbbVie access to a neuroscience-focused technology platform and an Alzheimer's drug candidate originally developed by Johnson & Johnson.

Pic: getty/andrewbrookes

Abzena announces major expansion of its biologics manufacturing facility

The expansion of its QC microbiology lab meets the growing demand for quality testing.

© Aldevron

Aldevron’s Anu Codaty on passion, leadership, and innovation

Anu Codaty, VP of global marketing and strategy at Aldevron, is blazing trails in biotech, inspired by a family legacy in medicine and driven to create life-changing therapies.

Pic: getty/monticello

AstraZeneca’s rare disease therapy Fasenra receives EU approval

The new treatment will be a competitor of GSK’s Nucala (mepolizumab), which was approved in 2018 as the first targeted treatment for the same rare immune disease.

Pic: getty/mikkelwilliam

Ottimo Pharma emerges from stealth mode with prominent leadership and a promising cancer therapy

Backed by Medicxi, Ottimo Pharma is going to be working on Jankistomig and is headed by David Epstein

© Getty Images

EC approves Janssen’s Darzalex-SC combo for multiple myeloma

New Darzelex SC quadruplet regimen approved by European Commission for newly diagnosed multiple myeloma patients.

Global Industry News

Trends

Spotlight

Women in Science: Sharmeen Roy - 'pharmacy is the perfect blend of all my favourite subjects'

Women in STEM: Gitte Barknowitz’s journey to leading global initiatives

Women in Science - Emmanuelle Cameau on growing stronger from challenges

Women in Science - Beate Mueller on the privilege of bringing solutions closer to patients

EU approves Regeneron’s bispecific antibody following US rejection

FDA approval of Regeneron’s myeloma drug delayed due to manufacturing issues

Breaking News: Lecanemab approved in UK but unavailable on NHS

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Adcendo and Multitude target cancer resistance to ADCs in $1BN deal

Follow us

Most popular News

Webinars

On-demand webinars

Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Mixed-Mode Chromatography Media Thermo Fisher Scientific - Biosciences

Featured Suppliers

All